1. Home
  2. INTS vs RAY Comparison

INTS vs RAY Comparison

Compare INTS & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.21

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Raytech Holding Limited Ordinary Shares

RAY

Raytech Holding Limited Ordinary Shares

HOLD

Current Price

$2.95

Market Cap

10.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
RAY
Founded
2012
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
INTS
RAY
Price
$4.21
$2.95
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$38.00
N/A
AVG Volume (30 Days)
57.5K
17.0K
Earning Date
05-07-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.84
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.15
52 Week High
$8.06
$5.99

Technical Indicators

Market Signals
Indicator
INTS
RAY
Relative Strength Index (RSI) 54.20 44.72
Support Level $0.32 $2.37
Resistance Level $8.06 $3.20
Average True Range (ATR) 0.22 0.28
MACD 0.08 -0.00
Stochastic Oscillator 92.75 47.29

Price Performance

Historical Comparison
INTS
RAY

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks: